Core Laboratory for Neuromolecular Production manager. The University of Montana. Our Lab. is a service facility funded by NINDS (NIH P30-NS055022) and dedicated to the synthesis and production of neurotransmitter-based small molecule ligands, probes, and bioconjugates (LPBs) at The University of Montana (UM).

At DermaXon, we are actively working to discover and develop novel therapeutic strategies to treat and prevent life-threatening chronic diseases such as Alzheimer’s disease, ichtyosis and neuropathic pain.

Research focussed in pain and cannabinoid in the department of anesthesiology and pain medicine at MD Anderson Cancer Center.

In charge of the full monitoring of a research project. This position implies the purchase, the design and synthesis of chemical libraries and planning of biological and physico-chemical assays. I was in charge of the chemical optimization (in term of bioavailability, toxicity and activity) for these projects. I was involved in the organisation of the clinical research trials for the proof of concept of the project

Purchase, the design and synthesis of chemical libraries and planning of biological and physico-chemical assays. I was in charge of the chemical optimization (in term of bioavailability, toxicity and activity)

In charge of the Combinatorial Chemistry Laboratory in Galderma R&D. The main goals were to design chemical libraries for screening, to create a parallel chemistry platform and to purchase targeted or diversified chemical libraries for HTS